Global Venous Stents Market: Overview This report on the Global Venous Stents market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel venous stents, increase in prevalence of chronic venous occlusion & other symptomatic venous disorders and their improved diagnosis are boosting the growth of the Global Venous Stents market. Improved access to the deep long veins located in the iliac and femoral portion of the body, and availability of well-qualified interventional cardiologists in the developed countries are some of the factors expected to drive the growth of Global Venous Stents market during the forecast period.
The venous stents report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on technology, application, disease indication, and geography.
A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises exhaustive mapping of all the products & companies operating in the global venous stents market, to help understand the competitive landscape in the market.
An overview of critical venous diseases such as May-Thurner Syndrome and Post Thrombotic Syndrome in terms of their prevalence, diagnosis, symptoms, and treatment options are provided. A brief snapshot of ongoing clinical trials in the U.S. is also provided for better understanding of venous stents scenario in the U.S. This report also provides market attractiveness and its analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the Global Venous Stents market.
Global Venous Stents Market: Segmentation Based on the technology, the Venous Stents market has been segmented into Iliac vein Stent Technology, Wallstent Technology, and Others. Iliac Vein Stent Technology is considered to be a leading segment of Venous Stents market, owing to the improved access to the deep veins of iliac area.
It is expected to continue to dominate the market in terms of revenue by 2025, which is attributed to the increasing investments by key players for the development of venous stents. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Different types of applications in the Venous Stents market are Leg, Chest, Abdomen, and Arm. Legs accounted for highest market revenue in 2016, and is expected to remain leading in terms of revenue during the forecast period. The dominance is attributed to the shift of patients’ preference towards minimally invasive interventional procedures for the occlusion in femoral & popliteal veins.
Based on disease indication, the global Venous Stents market is segmented into 5 major segments, which are Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae, and Others. Other disease segment comprised of venous anastomosis, restenosis, and venous occlusions among others. The others segment is anticipated to lead the market during the forecast period, owing to the government participation in the control of venous disorders, and research grants by public & private players to promote the R&D of innovative venous stents.
Global Venous Stents Market: Regional Outlook Geographically, the global Venous Stents has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa).
Global Venous Stents Market: Competitive Landscape The report also profiles major players in the Global Venous Stents based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Boston Scientific Corporation, C.
R. Bard, Inc., Jotec GmBH, Veniti, Inc., Gore Medical, Cook Medical, and Optimed Medizinische Instrumente GmBH.
The Global Venous Stents Market has been segmented as given below: Global Venous Stents Market, by Technology, Iliac Vein Stent Technology Wallstent Technology Others
Global Venous Stents Market, by Application, Leg Chest Abdomen Arm
Global Venous Stents Market, by Disease Indication, Chronic Deep Vein Thrombosis Post Thrombotic Syndrome May-Thurner Syndrome Hemodialysis/Arteriovenous Fistulae Others
Global Venous Stents Market, by Region North America U.S. Canada Europe Germany U.K. France Italy Spain Rest of Europe Asia Pacific India China Australia & New Zealand Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Middle East & Africa GCC Countries South Africa Israel Rest of Middle East & Africa
Our reports have been used by over 10K customers, including:
136 pages •
By Infiniti Research Limited
• Nov 2018
About Abrasives Absrasives are materials that are used to grind, abrade, or clean workpieces to give the desired shape and finish. They are used for polishing surfaces, buffing, honing, and sanding. Technavio’s analysts forecast the global abrasives market to grow at a CAGR of 5.65% during the period 2019-2023. Covered...
The Global Infectious Vaccines Partnering Terms and Agreements 2012 to 2018: Deal trends, players and financials report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right...
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2012-2018 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The report provides a detailed understanding and analysis of how and why companies enter business, product,...
Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H2 2018 Summary Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to 10 molecules. Out of which approximately 8 molecules are developed by companies and remaining by the universities/institutes. The latest report Toll Like...
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 220.127.116.11) - Pipeline Review, H2 2018 Summary According to the recently published report ’Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2018’; Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 18.104.22.168) pipeline Target constitutes...
The Global Vaccine Partnering Terms and Agreements 2010-2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in vaccine and adjuvant partnering deals Deal...
107 pages •
By Infiniti Research Limited
• Oct 2018
About High-altitude Pseudo Satellites High-altitude pseudo-satellites (HAPS) are aircraft, airships or balloons that fly in the stratosphere (12 miles to 31 miles above ground) and can provide a variety of services aver regional coverage areas. Technavio’s analysts forecast the global high-altitude pseudo satellites...
Interleukin 1 (IL1) - Pipeline Review, H2 2018 Summary Interleukin 1 (IL1) - Interleukin-1 is a cytokine which plays an important role regulation of immune and inflammatory responses. It helps leukocytes pass through blood vessel walls to sites of infection and causes fever by affecting areas of...
The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market size is expected to reach $1,180.7 million by 2024, rising at a market growth of 30.4% CAGR during the forecast period. Glaucoma is a progressive disease and is the major cause of irreversible blindness with an estimated burden to rise 111.8 million by 2040. This has increased...
113 pages •
By Infiniti Research Limited
• Oct 2018
About Bivalvia Bivalvia is a type of mollusc with a compressed body enclosed by a shell comprising two hinged parts. Technavio’s analysts forecast the Global Bivalvia Market to grow at a CAGR of 3.76% during the period 2019-2023. Covered in this report The report covers the present...